N6-Methyladenosine-5'-Triphosphate - (N-1013)
N6-Methyl-ATP, m6ATP
In stock
default
N-1013
Description
N6-methyl adenosine (N6-methyl ATP) is a base modified analog of adenosine and is found as a minor nucleoside in natural RNAs (Meyer et al.). N6-methyl ATP can substitute for ATP in some biological systems, and is a potent agonist for P2Y-purinoceptors in the guinea pig, taenia coli (Burnstock et al.). In vitro studies showed that N6-methyl ATP substituted for ATP and supported cytoskeletal filament-driven translocation of motor proteins (dynein, kinesin and myosin) (Schliwa et al. & Shimizu et al.).
N6-methyl ATP is also a substrate for RNA polymerase and can be used for preparation of modified RNA (Rohayem & Kariko et al.).
Product details
| Catalog No | N-1013 |
|---|---|
| Purity | ≥90% by AX-HPLC |
| Extinction Coefficient | 15,567 Lmol-1cm-1 at 265 nm |
| Molecular Formula | C11H18N5O13P3 (free acid) |
| Molecular Weight | 521.20 g/mole (free acid) |
| Salt Form | Li+ |
| Concentration | 100 mM |
| Buffer | H2O |
| Recommended Storage | -20°C or below |
| Other Name(s) | N6-Methyl-ATP, m6ATP |
| Application | Aptamers, Epigenetics/DNA Damage, In vitro Transcription, Mutagenesis, Photocrosslinking Studies |
| Backbone | 5'-Triphosphate |
| Base Analog(s) | Adenosine |
| Sugar Type(s) | RNA |
| Nucleotide Category | Base Modified RNA |
Technical documents
N-1013 Safety Data Sheet
Products faqs
Ask an Expert
Certificate of analysis
CoA search tool
Intellectual property
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission from TriLink No license under any patent or other intellectual property right of TriLink or its licensors is granted or implied by the purchase unless otherwise provided in writing.
TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.
Related products
References
- Missiaen, L.; Parys, J. B.; Smedt, H. D.; Sienaert, I.; Sipma, H.; Vanlingen, S.; Maes, K.; Casteels, R. . Effect of adenine nucleotides on myo-inositol-1,4,5-trisphosphate-induced calcium release.
- Karikó, Katalin; Muramatsu, Hiromi; Welsh, Frank A.; Ludwig, János; Kato, Hiroki; Akira, Shizuo; Weissman, Drew . Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
- Karikó, Katalin; Buckstein, Michael; Ni, Houping; Weissman, Drew . Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.
- Anderson, Bart R.; Muramatsu, Hiromi; Nallagatla, Subba R.; Bevilacqua, Philip C.; Sansing, Lauren H.; Weissman, Drew; Karikó, Katalin . Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.
- Anderson, Bart R.; Muramatsu, Hiromi; Jha, Babal K.; Silverman, Robert H.; Weissman, Drew; Karikó, Katalin . Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.
- Motorin, Yuri; Helm, Mark . RNA nucleotide methylation.
- Alarcón, Claudio R.; Lee, Hyeseung; Goodarzi, Hani; Halberg, Nils; Tavazoie, Sohail F. . N6-methyladenosine marks primary microRNAs for processing.
- Durbin, Ann Fiegen; Wang, Chen; Marcotrigiano, Joseph; Gehrke, Lee . RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling.
- Wang, Haiyan; Qi, Chunling; He, Wenhuan; Wang, Minghui; Jiang, Wenjing; Yin, Huanshun; Ai, Shiyun . A sensitive photoelectrochemical immunoassay of N(6)-methyladenosine based on dual-signal amplification strategy: Ru doped in SiO(2) nanosphere and carboxylated g-C(3)N(4).
- Potapov, Vladimir; Fu, Xiaoqing; Dai, Nan; Corrêa, Ivan R. Jr; Tanner, Nathan A.; Ong, Jennifer L. . Base modifications affecting RNA polymerase and reverse transcriptase fidelity.
- Lee, JH;Wang, R;Xiong, F;Krakowiak, J;Liao, Z;Nguyen, PT;Moroz-Omori, EV;Shao, J;Zhu, X;Bolt, MJ;Wu, H;Singh, PK;Bi, M;Shi, CJ;Jamal, N;Li, G;Mistry, R;Jung, SY;Tsai, KL;Ferreon, JC;Stossi, F;Caflisch, A;Liu, Z;Mancini, MA;Li, W; . Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation
- Chen, YG;Chen, R;Ahmad, S;Verma, R;Kasturi, SP;Amaya, L;Broughton, JP;Kim, J;Cadena, C;Pulendran, B;Hur, S;Chang, HY; . N6-Methyladenosine Modification Controls Circular RNA Immunity
- Liu, H;Begik, O;Lucas, MC;Ramirez, JM;Mason, CE;Wiener, D;Schwartz, S;Mattick, JS;Smith, MA;Novoa, EM; . Accurate detection of m6A RNA modifications in native RNA sequences
- Zhang, X;Wang, Y;Zhou, X; . A Ligation-Based qPCR Amplification Assay for the Radiolabeling-Free Detection of ATP/NAD+ with High Selectivity and Sensitivity
- Kim, K;van Galen, P;Hovestadt, V;Rahme, G;Andreishcheva, E;Shinde, A;Gaskell, E;Jones, D;Shema, E;Bernstein, B; . Systematic detection of m6A-modified transcripts at single-molecule and single-cell resolution
- Kontur, C; . RNA Methylation and Ythdf Readers in Posttranscriptional Regulation and Development
- Valentini, P;Pierattini, B;Zacco, E;Mangoni, D;Espinoza, S;Webster, N;Andrews, B;Carninci, P;Tartaglia, G;Pandolfini, L;Gustincich, S; . Towards SINEUP-based therapeutics: design of an in vitro synthesized SINEUP RNA
- Aditham, A;Shi, H;Guo, J;Zeng, H;Zhou, Y;Wade, SD;Huang, J;Liu, J;Wang, X; . Chemically Modified mocRNAs for Highly Efficient Protein Expression in Mammalian Cells
